SynAct
SYNACT.STSynAct Pharma AB Price (SYNACT.ST)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
32,523,854
(17.9041)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
SynAct Pharma ABCurrency: SEK
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
|||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 190,362.00 | 252,019.00 | 303,567.00 | 338,514.00 | 0.00 | 88,000.00 | 1,064,000.00 | 778,000.00 | |||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
0.00
+0% |
-190,362.00
+0% |
-252,019.00
+32% |
-303,567.00
+20% |
-338,514.00
+12% |
0.00
+0% |
-88,000.00
+0% |
-1,064,000.00
+1,109% |
-778,000.00
-27% |
|||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | |||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 216,000.00 | 324,000.00 | 0.00 | 0.00 | 21,814,000.00 | 15,174.00 | 22,788,000.00 | 60,490,000.00 | 70,067,000.00 | 105,055,000.00 | |||||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | 17,939,821.00 | 28,087,495.00 | 24,229,899.00 | 8,811,000.00 | 16,225,000.00 | 35,611,000.00 | 33,921,000.00 | |||||||||
| Selling, General & Admin... | 202,000.00 | 64,000.00 | 16,782,653.00 | 17,939,821.00 | 28,087,495.00 | 24,229,899.00 | 8,811,000.00 | 16,225,000.00 | 35,611,000.00 | 33,926,000.00 | |||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,000.00 | |||||||||
| Depreciation and Amortiz... | 83,000.00 | 85,000.00 | 190,362.00 | 252,019.00 | 303,567.00 | 338,514.00 | 381,059.00 | 88,000.00 | 1,064,000.00 | 778,000.00 | |||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 252,019.00 | 303,567.00 | 571,888.00 | -314,000.00 | -16,000.00 | 28,000.00 | 85,515,000.00 | |||||||||
| Total Operating Expenses | 503,000.00 | 474,000.00 | 16,782,653.00 | 18,191,840.00 | 28,391,062.00 | 24,801,787.00 | 31,285,000.00 | 76,699,000.00 | 105,706,000.00 | 224,496,000.00 | |||||||||
| Cost and Exponses | 503,000.00 | 474,000.00 | 16,973,015.00 | 18,191,840.00 | 28,391,062.00 | 24,801,787.00 | 31,285,000.00 | 76,699,000.00 | 105,706,000.00 | 224,496,000.00 | |||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-501,000.00
+0% |
-473,000.00
-6% |
-16,973,020.00
+3,488% |
-18,191,840.00
+7% |
-28,391,062.00
+56% |
-24,801,787.00
-13% |
-31,285,000.00
+26% |
-76,699,000.00
+145% |
-105,705,000.00
+38% |
-224,496,000.00
+112% |
|||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | |||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 456,000.00 | 551,000.00 | 0.00 | 0.00 | 0.00 | 2,388.00 | 30,000.00 | 105.00 | 47,000.00 | 220,000.00 | |||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,388,021.00 | 39,000.00 | 105,000.00 | 294,000.00 | 0.00 | |||||||||
| Total Other Income/Exp... | -458,000.00 | -637,000.00 | -19,355.00 | 155,386.00 | -156,407.00 | -2,302,489.00 | -19,000.00 | -110,000.00 | -1,360,000.00 | 220,000.00 | |||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -418,000.00 | -388,000.00 | -16,802,013.00 | -17,939,821.00 | -27,940,835.00 | -25,009,613.00 | -30,903,941.00 | -76,616,000.00 | -105,707,000.00 | -222,701,000.00 | |||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | |||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -959,000.00 | -1,025,000.00 | -16,992,370.00 | -18,036,454.00 | -28,244,407.00 | -27,104,276.00 | -31,304,000.00 | -76,809,000.00 | -107,065,000.00 | -224,276,000.00 | |||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | |||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 22,000.00 | 43,000.00 | -1,536,425.00 | -2,641,289.00 | -4,799,026.00 | -3,146,555.00 | -4,753,000.00 | -7,505,000.00 | -7,860,000.00 | -8,466,000.00 | |||||||||
| Net Income | |||||||||||||||||||
| Net Income | -937,000.00
+0% |
-982,000.00
+5% |
-15,455,945.00
+1,474% |
-15,395,165.00
0% |
-23,445,381.00
+52% |
-23,957,721.00
+2% |
-26,551,000.00
+11% |
-69,304,000.00
+161% |
-99,205,000.00
+43% |
-215,810,000.00
+118% |
|||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | |||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.13 | -0.14 | -1.30 | -1.24 | -1.70 | -1.62 | -1.23 | -2.67 | -3.60 | -6.64 | |||||||||
| Diluted EPS | -0.13 | -0.14 | -1.30 | -1.24 | -1.70 | -1.62 | -1.23 | -2.67 | -3.60 | -6.64 | |||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 7,210,000.00 | 7,210,000.00 | 11,856,089.00 | 12,424,851.00 | 13,798,752.00 | 14,824,089.00 | 21,650,065.00 | 25,968,531.00 | 27,585,001.00 | 32,523,000.00 | |||||||||
| Diluted Share Outstanding | 7,210,021.00 | 7,210,021.00 | 11,856,089.00 | 12,424,851.00 | 13,798,752.00 | 14,824,089.00 | 21,650,065.00 | 25,968,531.00 | 27,585,001.00 | 32,523,854.00 | |||||||||